Caspase requirement for neuronal apoptosis and neurodegeneration

IUBMB Life

Volumn 49, Issue 5, 2000, Pages 421-425

  Nicotera, Pierluigi ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Apoptosis; Caspases; Neurodegeneration

Indexed keywords

CASPASE; CASPASE INHIBITOR;

APOPTOSIS; DEGENERATIVE DISEASE; DRUG USE; ENZYME ACTIVATION; ENZYME ACTIVITY; NERVE DEGENERATION; NONHUMAN; REVIEW;

EID: 0033921961     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/152165400410272     Document Type: Review

References (56)

1. Schwanz, L. M., and Osborne, B. A. (1993) Programmed cell death, apoptosis and killer genes. Immunol. Today 14,582-590.
2. Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer 26, 239-247.
3. Yuan, J., and Horvitz, H. R. (1990) The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death. Dev. Biol. 138,33-41.
4. Schwanz, L. M., Smith, S. W., Jones, M. E. E., and Osbome, B. A. (1993) Do all programmed cell deaths occur via apoptosis? Proc. Natl. Acad. Sci. U.S.A. 90,980-984.
5. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M., and Horvitz, H. R. (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 -converting enzyme. Cell 75,641-652.
6. Samali, A., Zhivotovsky, B., Jones, D., Nagata, S., and Orrenius, S. (1999) Apoptosis: cell death defined by caspase activation. Cell Death Differ. 6, 49596.
7. Weil, M., Jacobson, M. D., Coles, H. S. R., Davies, T. J., Gardner, R. L., Raff, K. D., and Raff, M. C. (1996) Constitutive expression of the machinery for programmed cell death. J. Cell Biol. 133, 1053-1059.
8. Shaham, S., and Horvitz, H. R. (1996) Developing Caenorhabdilis elegans neurons may contain both cell-death protective and killer activities. Genes Dev. 10,578-591.
9. Nicholson, D., and Thornberry, N. A. (1997) Caspases: killer proteases. Trends Biochem. 22, 299-306.
10. Weidemann, A., Paliga, K., Diirrwang, U., Reinhard, F. B., Schuckert, O., Evin, G., and Masters, C. L. (1999) Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. J. Biol. Chem. 274,5823-5829.
11. Ellerby, L. M., Andrusiak, R. L., Wellington, C. L., Hackarn, A. S., Propp, S. S., Wood, J. D., Sharp, A. H., Margolis, R. L., Ross, C. A., Salvesen, G. S., Haydcn, M. R., and Bredesen, D. E. (1999) Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity. J. Biol. Chem. 274, 8730-8736.
12. Kobayashi, Y., Miwa, S., Merry, D. E., Kume, A., Mei, L., Doyu, M., and Sobue, G. (1998) Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat lengthdependent manner. Biochem. Biophys. Res. Commun. 252, 145-150.
13. Wellington, C. L., Ellerby, L. M., Hackam, A. S., Margolis, R. L., Trifiro, M. A., Singaraja, R., McCutcheon, K., Salvesen, G. S., Propp, S. S., Bromm, M., Rowland, K. J., Zhang, T., Rasper, D., Roy, S., Thornberry, N., Pinsky, L., Kakizuka, A., Ross, C. A., Nicholson, D. W., Bredesen, D. E., and Hayden, M. R. (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract.J. Biol. Chem. 273,9158-9167.
14. Gervais, F. G., Xu, D., Robertson, G. S., Vaillancourt, J. P., Zhu, Y., Huang, J., LeBlanc, A., Smith, D., Rigby, M., Shearman, M. S., Clarke, E. E., Zheng, H., Van Der Ploeg, L. H., Ruffolo, S. C., Thornberry, N. A., Xanthoudakis, S., Zamboni, R. J., Roy, S., and Nicholson, D. W. (1999) Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 97,395)06.
15. Van de Craen, M., de Jonghe, C., van den Brande, I., Declercq, W., van Gassen, G., van Criekinge, W., Vanderhoeven, I., Fiers, W., van Broeckhoven, C., Hendriks, L., and Vandenabcele, P. (1999) Identification of caspases that cleave presenilin-1 and presenilin-2. Five presenilin-1 (PS1) mutations do not alter the sensitivity of PS1 to caspases. FEES Lett. 445, 149-154.
16. Kuida,K.,Lippke,J.A.,Ku,G.,Harding,M.W.,Livingston,D. J., Su, M.S., and Flavell, R. A. (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-l converting enzyme. Science 267, 2000-2003.
17. Kuida, K., Zheng, T. S., Na, S., Kuan, C.-Y., Yang, D., Karasuyama, H., Rakic, P., and Flavell, R. A. (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384,368-372.
18. Hirsch, T., Marchetti, P., Susin, S. A., Dallaporta, B., Zamzami, N., Marzo, I., Geuskens, M., and Kroemer, G. (1997) The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15, 1573-1581.
19. Sarin, A., Williams, M. S., Alexander-Miller, M. A., Berzofsky, J. A., Zacharchuk, C. M., and Henkart, P. A. (1997) Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity 6, 209-215.
20. Xiang, J., Chao, D. T., and Korsmeyer, S. J. (1997) BAX-induced cell death may not require interleukin 1 -converting enzyme-like proteases. Proc. Nail. Acad. Sci. U.S.A. 93, 14559-14563.
21. Vercammen, D., Beyaert, R., Dcnecker, G., Goossens, V., Van Loo, G., Declercq, W., Grooten, J., Fiers, W., and Vandenabeele, P. (1998) Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187, 1477-1485.
22. Adjei, P. N., Kaufmann, S. H., Leung, W.-Y., Mao, F., and Gores, G. J. (1996) Selective induction of apoptosis in Hep 3B cells by toposiomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32. J. Clin. Invest. 98,2588-2596.
23. Grimm, L. M., Goldberg, A. L., Poirier, G. G., Schwanz, L. M., and Osborne, B. A. (1996) Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15,3835-3844.
24. Jaattela, M., Wissing, D., kokholm. K., Kallunki, T., and Egeblad, M. (1998) Hsp70 exerts its anti-apoptotic function downstream of caspase-3-Iike proteases. EMBO J. 17, 6124-6134.
25. Leist, M., Single, B., Castoldi, A. E, Kiihnle, S., and Nicotera, P. (1997) Intracellular ATP concentration: a switch deciding between apoptosis and necrosis. J. Exp. Med. 185,1481-1486.
26. Bomer, C., and Monney, L. (1999) Apoptosis without caspases: an inefficient molecular guillotine? Cell Death Differ. 6,497-507.
27. McCarthy, N. J., Whyte, M. K. B., Gilbert, C. S., and Evan, G. I. (1997) Inhibition of Ced-3/lCE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the bcl-2 homologue bak. J. Cell Biol. 136,215-227.
28. Susin, S. A., Zamzami, N., Castedo, M., Daugas. E., Wang, H.-G., Geley, S., Fassy, F., Reed, J. C., and Kroemer, G. (1997) The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-l/CD95- and ceramide-induced apoptosis. J. Exp. Med. 186,25-37.
29. Williams, M. S., and Henkart, P. A. (1994) Apoptotic cell death induced by intracellular proteolysis. J. Immunol. 153,4247-4255.
30. Johnston, J. A., Ward, C. L., and Kopito, R. R. (1998) Aggresomes: a cellular response to misfolded proteins.J. Cell Biol. 143, 1883-1898.
31. Levine, R. L., Oliver, C. N., Fulks, R. M., and Stadtman, E. R. (1981) Turnover of bacterial gluatmine synthase: oxidative inactivation precedes proteolysis. Proc. Natl. Acad. Sci. U.S.A. 78,2120-2125.
32. 2+ and the stimulation of a nonlysosomal proteolytic system. J. Biol. Chem. 261,14628-14635.
33. Leist, M., Gantner, F., Bohlinger, I., Tiegs, G., Germann, P. G., and Wendel, A. (1995) Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J. Palhol. 146, 1220-1234.
34. Volbracht, C., Leist, M., and Nicotera P. (1999) ATP controls neuronal apoptosis triggered by microtubule breakdown or potassium depravation. Mot. Med. 5,477-489.
35. Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., and Nicotera, P. (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973.
36. Liu, X., Kirn, C. N., Yang, J., Jemmerson, R., and Wang, X. (1996) Induction of apoptotic program in cell-free extracts: requirement fordATP and cytochrome c. Cell 86, 147-157.
37. Leist, M., Single, B., Naumann, H., Fava, E., Simon, B., Kuhnle, S., and Nicotera, P. (1999) Nitric oxide inhibits execution of apoptosis at two distinct ATP-dependent steps upstream and downstream of mitochondrial cytochrome c release. Biochem. Biophys. Res. Commun. 258,215-221.
38. Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O., and Tagliavini, F. (1993) Neurotoxicity of a priori protein fragment. Nture 362,543-546.
39. Forloni, G., Bugiani, O., Tagliavini, F., and Salmona, M. (1996) Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments. Mot. Chem. Neuropathol. 28, 163-171.
40. Saudou, F., Finkbeiner, S., Devys, D., and Greenberg, M. E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95,55-66.
41. Kirn, M., Lee, H. S., LaForet, G., Mclntyre, C., Martin, E. J., Chang, P., Kirn, T. W., Williams, M., Reddy, P. H., Tagle, D., Boyce, F. M., Won, L., Heller, A., Aronin, N., and DiFiglia, M. (1999) Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J. Neumsci. 19, 964-973.
42. Shoubridge, E. A. (1998) Mitochondria! encephalomyopathies. Curr. Opin. Neural. 11,491-496.
43. O'Leary, D. D., and Koester, S. E. (1993) Development of projection neuron types, axon pathways, and patterned connections of the mammalian cortex. Neuron 6,991-1006.
44. Finn, J. T., Weil, M., Archer, F., Siman, R., Srinivasan, A., and Raff, M. C. (2000). Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J Neitwsci. 20, 1333-1341
45. Charriaut-Marlangue, C., Aggoun-Zouaoui, D., Represa, A., and Ben-Ari, Y. (1996) Apoptotic features of selective neuronal death in ischemia, epilepsy and gp!20 toxicity. Trends Neurosci. 19, 109-114.
46. Mattson, M. P. (1998) Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neuroscience 21, 53-57.
47. Lipton, S. A., and Rosenberg, P. A, (1994) Excitatory amino acids as a final common pathway for neurologic disorders. A'. Engl. J. Med. 330, 613-622.
48. Fink, K., Zhu, J., Namura, S., Shimizu-Sasamata, M., Endres, M., Ma, J., Dalkara, T., Yuan, J., and Moskowitz, M. A. (1998) Prolonged therapeutic window for ischémie brain damage caused by delayed caspase activation. J. Cereb. Blood Flow Metab. 18, 1071-1076.
49. Schulz, J. B., Weller, M., and Moskowitz, M. A. (1999) Caspases as treatment targets in stroke and neurodegenerative diseases. Ann. Neural. 45,421129.
50. Schierle, G. S., Hansson, O., Leist, M., Nicotera, P., Widner, H., and Brundin, P. (1999) Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat. Med. 5,97-100.
51. Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., and Morion, A. J. (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19,3248-3257.
52. Chapman, P. E, White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V., Hyman, B. T., Younkin, S. G., and Hsiao, K. K. (1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2,271-276.
53. Hansson, O., Petersen, A., Leist, M., Nicotera, P., Castilho, R. F., and Brundin, P. (1999) Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc. Nail. Acad. Sci. U.S.A. 96, 8727-8732.
54. Sanchez, I., Xu, C. J., Juo, P., Kakizaka, A., Blenis, J., and Yuan, J. (1999) Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22, 623-633.
55. Miyashita, T., Matsui, J., Ohtsuka, Y., Mami, U., Fujishirna, S., OkamuraOho, Y, Inoue, T., and Yamada, M. (1999) Expression of extended polyglutamine sequentially activates initiator and effector caspases. Biochem. Biophys. Res. Commun. 257, 724-730.
56. Ona, V. O., Li, M., Vonsattel, J. P., Andrews, L. J., Khan, S. Q., Chung, W. M., Frey, A. S., Menon, A. S., Li, X. J., Stieg, P. E., Yuan, J., Penney, J. B., Young, A. B., Cha, J. H., and Friedlander, R. M. (1999) Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399, 263-267.